An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Status:
Terminated

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

The primary objective of the study is to characterize the safety profile and duration of bronchodilation of a single dose of inhaled TV48108.

Phase 1

Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products, R&D Inc.

Ipratropium